质量即生命 — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

成为合作伙伴
ALIREPOTINIB
Rx
肿瘤学 & 血液学

ALIREPOTINIB

瑞波替尼 (Repotrectinib)
Generic (INN)
瑞波替尼 (Repotrectinib)
Strength
40 mg
Packaging
60 粒/瓶。
Indication
局部晚期或转移性 ROS1 阳性非小细胞肺癌（NSCLC）成年患者。
Registration No.
To be added
Package Insert
English & Lao (PDF)
Documents
Registration certificateTo be added
Medicine safety & reporting

More in 肿瘤学 & 血液学

View all →
ALIMOLOTINI 200mg
ALIMOLOTINI 200mg
莫博赛替尼 (Mobocertinib?)
ALIGIRITINIB
ALIGIRITINIB
吉列替尼 (Gilteritinib)
LORLATINIB 25mg
LORLATINIB 25mg
劳拉替尼 (Lorlatinib)
ALILSAZOMI
ALILSAZOMI
枸橼酸伊沙佐米 (Ixazomib citrate)
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Regenerative CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Regenerative Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文